Hostname: page-component-7b7567c8c-9cwtv Total loading time: 0 Render date: 2026-11-19T14:56:56.771Z Has data issue: false hasContentIssue false

Impact of tele-antimicrobial stewardship at two small community hospitals in partnership with an academic medical center: two years of experience

Published online by Cambridge University Press:  23 September 2024

Jennifer K. Ross
Affiliation:
Fairview Pharmacy Services, Minneapolis, MN, USAM Health Fairview University of Minnesota Medical Center, Minneapolis, MN, USA
Aditya A. Chandorkar*
Affiliation:
M Health Fairview University of Minnesota Medical Center, Minneapolis, MN, USADivision of Infectious Diseases and International Medicine, University of Minnesota, Minneapolis, MN, USA
*
Corresponding author: Aditya Chandorkar; Email: chand716@umn.edu

Abstract

Objective:

To analyze the impact of a fully remote tele-antimicrobial stewardship program (TASP) at two small community hospitals in partnership with an academic medical center.

Design:

Retrospective survey from August 1, 2020, to July 31, 2022.

Setting:

A TASP, co-led by an infectious diseases (ID) physician and ID pharmacist, was implemented at M Health Fairview (MHF) Northland, a 21-bed hospital, and at MHF Lakes, a 49-bed hospital. The ID physician and ID pharmacist are located at the University of Minnesota Medical Center.

Methods:

Antimicrobial stewardship interventions were tracked monthly. Restricted antimicrobial days of therapy per 1000 patient days (DOT/1000 PD) were also tracked monthly and two years pre and postimplementation data were compared. All annual antimicrobial expenditures were followed.

Results:

For the first two TASP years, a total of 789 antimicrobial interventions were made with 85.6% being accepted. Restricted antimicrobial use trended down from 142.93 to 113.97 DOT/1000 PD at MHF Northland. A smaller decrease from 106.31 to 103.12 DOT/1000 PD was seen at MHF Lakes. Annual antimicrobial costs per total patient days decreased. MHF Northland hospital’s annual antimicrobial expenditures per total patient days fell from $18.89 in 2019 (preimplementation) to $6.64. MHF Lakes followed a similar trend, decreasing from $11.20 to $5.36.

Conclusions:

A fully remote TASP in partnership with an academic medical center for two small community hospitals resulted in high rates of accepted interventions sustained over two years. Restricted antimicrobial use and antimicrobial costs trended down.

Information

Type
Original Article
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2024. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America
Figure 0

Figure 1.The daily TASP workflow with MHF Lakes Hospital and MHF Northland. ID expertise located at UMMC.

Figure 1

Table 1.Restricted antimicrobial agents at MHF TASP hospitals. Patients prescribed at least one restricted antimicrobial are included in the purview of the TASP

Figure 2

Table 2.Monthly TASP accepted and total interventions

Figure 3

Figure 2.Monthly restricted antimicrobial use (DOT/1000 PD).

Figure 4

Table 3.Average restricted antimicrobial utilization for the 24-month baseline and 24-month intervention periods

Figure 5

Figure 3.Annual TASP all antimicrobial expenditures per patient day.